<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">surgonco</journal-id><journal-title-group><journal-title xml:lang="ru">Креативная хирургия и онкология</journal-title><trans-title-group xml:lang="en"><trans-title>Creative surgery and oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-3093</issn><issn pub-type="epub">2307-0501</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24060/2076-3093-2022-12-3-250-255</article-id><article-id custom-type="elpub" pub-id-type="custom">surgonco-722</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Клинический опыт успешного хирургического лечения гигантской метастатической саркомы легкого</article-title><trans-title-group xml:lang="en"><trans-title>Clinical Case of Successful Surgical Treatment for Giant Cell Metastatic Lung Sarcoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1367-4878</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баксиян</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Baksiyan</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>онкологическое отделение хирургических методов лечения, кафедра онкологии и радиационной медицины с курсом медицинской физики</p><p>Москва</p></bio><bio xml:lang="en"><p>Oncological Surgery Unit, Department of Oncology andRadiation Medicine with a course of Medical Physics</p><p>Moscow</p></bio><email xlink:type="simple">galust_1983@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9918-0851</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Степанянц</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Stepanyants</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., онкологическое отделение хирургических методов лечения, кафедра онкологии и радиационной медицины с курсом медицинской физики</p><p>Москва</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Oncological Surgery Unit, Department ofOncology and Radiation Medicine with a course of Medical</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Астахов</surname><given-names>Д. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Astakhov</surname><given-names>D. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., онкологическое отделение хирургических методов лечения, кафедра онкологии и радиационной медицины с курсом медицинской физики</p><p>Москва</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Oncological Surgery Unit, Department of Oncology and Radiation Medicine with a course of Medical Physics</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5391-6843</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аксененко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Aksenenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н, онкологическое отделение хирургических методов лечения</p><p>Москва</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Oncological Surgery Unit</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1825-1871</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Завьялов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zavyalov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, онкологический центр, кафедра онкологиии радиационной медицины с курсом медицинской физики</p><p>Москва</p></bio><bio xml:lang="en"><p>Dr.Sci. (Med.), Professor, Oncology Center, Department of Oncology and Radiation Medicine with a course of Medical Physics</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственный научный центр Российской Федерации – Федеральный медицинский биофизический центр имени А.И. Бурназяна Федерального медико-биологического агентства; Медико-биологический университет инноваций и непрерывного образования Федерального медицинского биофизического центра им. А.И. Бурназяна Федерального медико-биологического агентства</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A.I. Burnazyan Federal Medical Biophysical Center FMBA; Medical and Biological School of Innovation and Continuous Education, A.I. Burnazyan Federal Medical Biophysical Center FMBA</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Государственный научный центр Российской Федерации – Федеральный медицинский биофизический центр имени А.И. Бурназяна Федерального медико-биологического агентства</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A.I. Burnazyan Federal Medical Biophysical Center FMBA</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2022</year></pub-date><volume>12</volume><issue>3</issue><fpage>250</fpage><lpage>255</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Баксиян Г.А., Степанянц Н.Г., Астахов Д.Н., Аксененко А.В., Завьялов А.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Баксиян Г.А., Степанянц Н.Г., Астахов Д.Н., Аксененко А.В., Завьялов А.А.</copyright-holder><copyright-holder xml:lang="en">Baksiyan G.A., Stepanyants N.G., Astakhov D.N., Aksenenko A.V., Zavyalov A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surgonco.ru/jour/article/view/722">https://www.surgonco.ru/jour/article/view/722</self-uri><abstract><sec><title>Введение</title><p>Введение. Саркомы – группа гетерогенных неэпителиальных злокачественных опухолей, происходящих из соединительной ткани. Данные опухоли характеризуются крайне агрессивным местным ростом, относительно малой частотой лимфогенных метастазов, преимущественной и ранней гематогенной генерализацией. Наиболее часто эти опухоли метастазируют в легкие.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В статье описан случай успешного хирургического лечения гигантского метастаза фибросаркомы забрюшинного пространства в легкое.</p></sec><sec><title>Результаты</title><p>Результаты. Успех лечения больных саркомами зависит прежде всего от глобального понимания врачами-онкологами сложных вопросов патогенеза, гистологических форм и принципов комплексной терапии этой сложной, полиморфной группы злокачественной патологии. Чем более рано диагностирован первичный очаг, чем скорее и радикальнее выполнено хирургическое лечение и чем более верно проведена лекарственная терапия, тем лучше результат комплексного лечебного подхода. Аналогичным образом следует действовать и при вторичных очагах саркомы, не дожидаясь момента, когда их размеры и местное распространение будут являться противопоказанием к хирургическому лечению.</p></sec><sec><title>Заключение</title><p>Заключение. Запущенные случаи сарком диктуют необходимость комбинированных и расширенных хирургических вмешательств, один из успешных примеров которых описан в данной статье.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Sarcomas refer to a group of heterogeneous non-epithelial malignant tumors originating from connective tissue. These tumors are characterized by extremely aggressive local growth, relatively low incidence of lymphogenic metastases, predominant and early hematogenic generalization. These tumors most oft en metastasize to the lungs.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The paper describes a case of successful surgical treatment for a giant retroperitoneal fibrosarcoma metastasis to the lung.</p></sec><sec><title>Results</title><p>Results. Successful treatment for sarcoma depends primarily on a global understanding by oncologists of the complex pathogenesis, histological forms and principles of comprehensive treatment for this complex, polymorphic group of malignant pathologies. The earlier the primary site is diagnosed, the sooner and more definitely the surgical treatment is performed, and the more correctly the drug therapy is carried out, the better the result of the complex treatment approach. Similarly, sarcoma secondary sites should be treated proactively – without waiting until their size and local spread contraindicate surgical treatment. Conclusion. Neglected sarcoma cases indicate the need for combined and extended surgical interventions, one successful example of which is described in this paper.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>фибросаркома забрюшинного пространства</kwd><kwd>гигантская саркома</kwd><kwd>легкие</kwd><kwd>метастазы</kwd><kwd>торакотомия</kwd><kwd>лимфодиссекция</kwd><kwd>компрессионный синдром</kwd></kwd-group><kwd-group xml:lang="en"><kwd>retroperitoneal fibrosarcoma</kwd><kwd>giant cell sarcoma</kwd><kwd>lungs</kwd><kwd>metastases</kwd><kwd>thoracotomy</kwd><kwd>lymph node dissection</kwd><kwd>compression syndrome</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2017 г. Москва: МНИОИ им. П.А. Герцена, филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2018. 250 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinsky V.V., Petrova G.V. (ed.) Malignant neoplasms in Russia in 2017. M.: P.A Gertsen Moscow Research Oncology Institute — branch of the National Medical Research Center for Radiology; 2018. 250 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Arora R.D., Shaikh H. Osteogenic Sarcoma. 2022 Jun 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 33085324</mixed-citation><mixed-citation xml:lang="en">Arora R.D., Shaikh H. Osteogenic Sarcoma. 2022 Jun 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 33085324</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ye C., Dai M., Zhang B. Risk factors for metastasis at initial diagnosis with Ewing sarcoma. Front Oncol. 2019;9:1043. DOI: 10.3389/fonc.2019.01043</mixed-citation><mixed-citation xml:lang="en">Ye C., Dai M., Zhang B. Risk factors for metastasis at initial diagnosis with Ewing sarcoma. Front Oncol. 2019;9:1043. DOI: 10.3389/fonc.2019.01043</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sasi A., Ganguly S., Biswas B., Pushpam D., Kumar A., Agarwala S., et al. Development and validation of a prognostic score at baseline diagnosis for Ewing sarcoma family of tumors: a retrospective single institution analysis of 860 patients. Am J Transl Res. 2022;14(2):927–41. PMID: 35273696</mixed-citation><mixed-citation xml:lang="en">Sasi A., Ganguly S., Biswas B., Pushpam D., Kumar A., Agarwala S., et al. Development and validation of a prognostic score at baseline diagnosis for Ewing sarcoma family of tumors: a retrospective single institution analysis of 860 patients. Am J Transl Res. 2022;14(2):927–41. PMID: 35273696</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Li W., Zhang S. Survival of patients with primary osteosarcoma and lung metastases. J Buon. 2018;23(5):1500–4. PMID: 30570878</mixed-citation><mixed-citation xml:lang="en">Li W., Zhang S. Survival of patients with primary osteosarcoma and lung metastases. J Buon. 2018;23(5):1500–4. PMID: 30570878</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Huang X., Zhao J., Bai J., Shen H., Zhang B., Deng L., et al. Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-base d study. J Bone Oncol. 2019;16:100230. DOI: 10.1016/j.jbo.2019.100230</mixed-citation><mixed-citation xml:lang="en">Huang X., Zhao J., Bai J., Shen H., Zhang B., Deng L., et al. Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-base d study. J Bone Oncol. 2019;16:100230. DOI: 10.1016/j.jbo.2019.100230</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wan L., Tu C., Qi L., Li Z. Survivorship and prognostic factors for pleomorphic liposarcoma: a population-based study. J Orthop Surg Res. 2021;16(1):175. DOI: 10.1186/s13018-021-02327-3</mixed-citation><mixed-citation xml:lang="en">Wan L., Tu C., Qi L., Li Z. Survivorship and prognostic factors for pleomorphic liposarcoma: a population-based study. J Orthop Surg Res. 2021;16(1):175. DOI: 10.1186/s13018-021-02327-3</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gusho C.A., Fice M.P., O’Donoghue C.M., Gitelis S., Blank A.T. A Population-based analysis of lymph node metastasis in extremity soft tissue sarcoma: an update. J Surg Res. 2021;262:121–9. DOI: 10.1016/j.jss.2021.01.005</mixed-citation><mixed-citation xml:lang="en">Gusho C.A., Fice M.P., O’Donoghue C.M., Gitelis S., Blank A.T. A Population-based analysis of lymph node metastasis in extremity soft tissue sarcoma: an update. J Surg Res. 2021;262:121–9. DOI: 10.1016/j.jss.2021.01.005</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Outani H., Imura Y., Tanaka T., Takenaka S., Oshima K., Hamada K., et al. Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis. Int J Clin Oncol. 2018;23(1):181–8. DOI: 10.1007/s10147-017-1179-x</mixed-citation><mixed-citation xml:lang="en">Outani H., Imura Y., Tanaka T., Takenaka S., Oshima K., Hamada K., et al. Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis. Int J Clin Oncol. 2018;23(1):181–8. DOI: 10.1007/s10147-017-1179-x</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Stork T., Boemans R., Hardes J., Streitbürger A., Dirksen U., Pöttgen C., et al. Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma. BMC Cancer. 2021;21(1):375. DOI: 10.1186/s12885-021-08073-3</mixed-citation><mixed-citation xml:lang="en">Stork T., Boemans R., Hardes J., Streitbürger A., Dirksen U., Pöttgen C., et al. Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma. BMC Cancer. 2021;21(1):375. DOI: 10.1186/s12885-021-08073-3</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Knebel C., Lenze U., Pohlig F., Lenze F., Harrasser N., Suren C., et al. Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years. BMC Cancer. 2017;17(1):410. DOI: 10.1186/s12885-017-3398-y</mixed-citation><mixed-citation xml:lang="en">Knebel C., Lenze U., Pohlig F., Lenze F., Harrasser N., Suren C., et al. Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years. BMC Cancer. 2017;17(1):410. DOI: 10.1186/s12885-017-3398-y</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wan L., Tu C., Qi L., Li Z. Survivorship and prognostic factors for pleomorphic liposarcoma: a population-based study. J Orthop Surg Res. 2021;16(1):175. DOI: 10.1186/s13018-021-02327-3</mixed-citation><mixed-citation xml:lang="en">Wan L., Tu C., Qi L., Li Z. Survivorship and prognostic factors for pleomorphic liposarcoma: a population-based study. J Orthop Surg Res. 2021;16(1):175. DOI: 10.1186/s13018-021-02327-3</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Чиссов В.И., Трахтенберг А.Х., Паршин В.Д. Пикин О.В. Хирургия метастазов сарком в легких. Российский онкологический журнал. 2005;5:4–7.</mixed-citation><mixed-citation xml:lang="en">Chissov V.I., Trakhtenberg A. Kh., Parshin V.D., Likin O.V. Surgery of sarcoma metastases to the lungs. Russian Journal of Oncology. 2005;5:4–7 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Смоленов Е.И., Рагулин Ю.А., Стародубцев А.Л., Курильчик А.А. и др. Хирургический метод в лечении множественных метастазов в легких при саркомах костей и мягких тканей. Сибирский онкологический журнал. 2015;1(3):45–50.</mixed-citation><mixed-citation xml:lang="en">Smolenov E.I., Ragulin Yu.A., Starodubtsev A.L., Kuril’chik A.A., Ivanov V.E., Zubarev A.L. Surgical treatment of multiple lung metastasis in patient with soft issue and visceral sarcomas. Siberian Journal of Oncology. 2015;1(3):45–50 (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
